Supplier Review
Reviewed March 17, 2026
Is WuXi TIDES legit?
The buyer-side answer is: it looks substantial, but the exact contracting and manufacturing path still matters.
As of March 17, 2026, WuXi TIDES publicly says it operates as a peptide and oligonucleotide
CRDMO platform within WuXi AppTec, with more than 1,600 scientists across 10 R&D and
manufacturing sites, including large-scale peptide and oligo capability in Changzhou. Those are
supplier claims, not independent buyer-side verification.
Public claims reviewed
- WuXi TIDES says it supports discovery, development, and manufacturing for peptides, oligos, and conjugates.
- WuXi TIDES says it has more than 1,600 scientists across 10 R&D and manufacturing sites.
- WuXi AppTec says its Changzhou site supports large-scale oligonucleotide and peptide manufacturing.
- The platform presents itself as serving projects from preclinical through commercial scale.
Source pages reviewed March 17, 2026:
WuXi TIDES homepage,
WuXi TIDES about page,
WuXi AppTec Changzhou facility announcement.
What a buyer should verify before trusting those claims
- Which WuXi legal entity is quoting, contracting, and responsible for batch release.
- Which specific site would make the peptide or intermediate relevant to your program.
- Whether the GMP, scale, and project-stage claims on the public site match your exact scope.
- Whether your material fits a WuXi TIDES workstream or is being routed elsewhere within the broader group.
- Whether the buyer packet contains batch-specific documentation rather than relying on platform-level brand strength.
Signals that justify a deeper screen
- The program is high-value enough that entity or site confusion creates real procurement risk.
- You are relying on group reputation rather than specific evidence tied to your material.
- The supplier’s public footprint is broader than the concrete quality packet you were given.
- You need to distinguish platform-scale marketing language from the exact production path for your order.
APV view
WuXi TIDES appears to be a large and credible platform, but large platforms still need
entity, site, and document-level confirmation before a buyer should treat them as qualified.